HALT-C: Results of Maintenance Peginterferon for Advanced Chronic HCV
Long-term therapy with peginterferon did not improve outcomes in HCV patients with advanced fibrosis and no response to previous therapy.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)